Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
Top Cited Papers
Open Access
- 12 March 2020
- journal article
- review article
- Published by Elsevier BV in International Journal of Infectious Diseases
- Vol. 94, 91-95
- https://doi.org/10.1016/j.ijid.2020.03.017
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Burden of diabetes, hyperglycaemia in China from to 2016: Findings from the 1990 to 2016, global burden of disease studyDiabetes & Metabolism, 2018
- Sexual Dimorphism in Innate ImmunityClinical Reviews in Allergy & Immunology, 2017
- Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus InfectionThe Journal of Immunology, 2017
- Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysisInternational Journal of Infectious Diseases, 2016
- Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014Emerging Infectious Diseases, 2016
- Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011–2012: Hospital-based Influenza Morbidity & Mortality (HIMM) surveillanceJournal of Infection and Chemotherapy, 2014
- Populations at risk for severe or complicated influenza illness: systematic review and meta-analysisBMJ, 2013
- Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort studyThorax, 2013
- Connecting Type 1 and Type 2 Diabetes through Innate ImmunityCold Spring Harbor Perspectives in Medicine, 2012
- Tuberculosis and diabetes mellitus: convergence of two epidemicsThe Lancet Infectious Diseases, 2009